Literature DB >> 512927

Acrylic microspheres in vivo. I. Distribution and elimination of polyacrylamide microparticles after intravenous and intraperitoneal injection in mouse and rat.

I Sjöholm, P Edman.   

Abstract

Microspheres of 14C-labeled highly cross-linked polyacrylamide (mean diameter 0.25-0.30 micron) have been prepared by emulsion polymerization. The label was introduced in the polymer via the cross-linking monomer. N,N'-[14C]methylenebisacrylamide. The microparticles were used to follow qualitatively and quantitatively the distribution and the fate of polyacrylamide in mouse and rat after i.v. and i.p. injection. The polyacrylamide particles are rapidly cleared from the circulation (t 1/2 in rat approximately 40 min) by macrophages of the reticuloendothelial system. They are mainly (about 80%) found in the liver and spleen both after i.v. and i.p. injection (4.1 mg given totally to mice weighing 20-25 g). They can also be detected early (1 hr after i.v. injection) in the bone marrow, and particle aggregates are also initially found in the lungs, although no respiratory problems were noted. After about 16 weeks, the radioactivity rapidly decreases in the liver and spleen, with t 1/2 10 to 14 weeks and 15 to 24 weeks, respectively, depending on the route of administration. Radioactivity in the gut and gut walls detected 2 months after injection suggests that the polyacrylamide is slowly metabolized. No toxic effects-apart from transient hepatospleenomegaly-were detected in mice 45 weeks after they were given a total of 9.8 mg of polyacrylamide.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512927

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics.

Authors:  R J Stenekes; O Franssen; E M van Bommel; D J Crommelin; W E Hennink
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

Review 2.  Mesenchymal stem cells as therapeutics.

Authors:  Biju Parekkadan; Jack M Milwid
Journal:  Annu Rev Biomed Eng       Date:  2010-08-15       Impact factor: 9.590

Review 3.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

Review 4.  To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells.

Authors:  Ilia A Droujinine; Mark A Eckert; Weian Zhao
Journal:  Oncotarget       Date:  2013-05

5.  Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases.

Authors:  Jacques Lux; Alexander G White; Minnie Chan; Carolyn J Anderson; Adah Almutairi
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

Review 6.  Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells.

Authors:  Anastasia Brooks; Kathryn Futrega; Xiaowen Liang; Xiaoling Hu; Xin Liu; Darrell H G Crawford; Michael R Doran; Michael S Roberts; Haolu Wang
Journal:  Stem Cells Transl Med       Date:  2017-12-06       Impact factor: 6.940

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.